NanoCarrier Co., Ltd
4571
End-of-day quote Tokyo - 01/17
389JPY
-1.02%
Prev.393.0000
Open389.0000
High396.0000
Low386.0000
Volume480 400
Financials
Sales 2019 460 M
EBIT 2019 -
R. net 2019 -2 222 M
Tréso. 2019 3 900 M
Rend. 2019 -
P/E ratio 2019 -
P/E ratio 2020 1 965,00
EV / Sales 2019 31,3x
EV / Sales 2020 5,19x
Capitalization 18 319 M
Company
NanoCarrier Co., Ltd. is a Japan-based biopharmaceutical products developer. The Company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It is engaged in the research, development, manufacture, and sale of anti-cancer drugs based on micellar...
Sector :
Bio Therapeutic Drugs
Calendar :
2019-02-12 Earnings Release
Trading Rating : -
Investor Rating :
Latest news
2018NANOCARRIER CO., LTD. : quaterly earnings release
2018NANOCARRIER : VBL falls on Phase III glioblastoma miss
AQ
2018NANOCARRIER : VBL Therapeutics Receives Milestone Payment From NanoCarrier Under Licensing Agreement for VB-111 in Japan
AQ
2016NANOCARRIER CO., LTD. : half-yearly earnings release
2016NANOCARRIER CO., LTD. : quaterly earnings release
2016NANOCARRIER CO., LTD. : annual earnings release
2014NANOCARRIER CO., LTD. : SPLIT: 100 of 1
FA
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance417417602
Spread/Res.-6,7%-6,7%-35%
Spread/Supp.36%36%26%
Support285285309